Quarterly Earnings, Market Activity, Regulatory Updates, Strategic Agreements, and Product Launch - Research Reports on Sanderson, Philip Morris, MetLife, 3M and GoPro

NEW YORK, August 29, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Sanderson Farms, Inc. (NASDAQ: SAFM), Philip Morris International, Inc. (NYSE: PM), MetLife, Inc. (NYSE: MET), 3M Company (NYSE: MMM) and GoPro, Inc. (NASDAQ: GPRO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6078-100free.

--
Sanderson Farms, Inc. Research Reports
On August 26, 2014, Sanderson Farms, Inc. (Sanderson) announced its Q3 FY 2014 financial results (period ended July 31, 2014). The Company's net sales in the quarter rose 4.0% YoY to $768.4 million. Sanderson's net income for the quarter came in at $76.1 million or $3.30 per diluted share, compared with $67.9 million, or $2.95 per diluted share, in Q3 FY 2013. Analysts polled by Zacks Investment Research expected the Company's net income at $3.77 per share and revenues at $778.7 million. Shares of the Company slipped 5.60% to end at $89.79 following the announcement. The Chairman and CEO Joe F. Sanderson, Jr. said that the Q3 FY 2014 results were affected by accruals booked for the Company's bonus award program and a contribution to the Company's employee stock ownership plan. Also, lower than anticipated volume processed at the Company's poultry plants affected the performance during the quarter, Sanderson added. The full research reports on Sanderson are available to download free of charge at:

http://www.analystsreview.com/Aug-29-2014/SAFM/report.pdf

--
Philip Morris International, Inc. Research Reports
On August 26, 2014, the stock of Philip Morris International, Inc. (Philip Morris) gained 0.08% to end the session at $85.26. During the session, the stock opened at $85.24, and fluctuated in the range of $84.83 - $85.46. Philip Morris' stock has a 52-week high of $91.81 and a 52-week low of $75.28. Over the last one month, the Company's stock increased by 0.48%, compared to the Dow Jones Industrial Average, which rose 0.86% during the same period. The full research reports on Philip Morris are available to download free of charge at:

http://www.analystsreview.com/Aug-29-2014/PM/report.pdf

--
MetLife, Inc. Research Reports
On August 21, 2014, Reuters reported that the U.S. Financial Stability Oversight Council (FSOC) has taken the next step to determine if New York based insurer Metlife Inc. (Metlife) can be designated as a systemically important financial institution. According to Reuters, the U.S. FSOC has closed the evidentiary record on Metlife, which is the last formal step before the council takes its decision. Reuters added that the tag of systemically important financial institution will subject Metlife to stricter capital and risk management oversight by financial regulators. The full research reports on MetLife are available to download free of charge at:

http://www.analystsreview.com/Aug-29-2014/MET/report.pdf

--
3M Company Research Reports
On August 26, 2014, 3M Company (3M) reported that its 3M Critical & Chronic Care Solutions division reached a group purchasing agreement with health care alliance company Premier, Inc. (Premier) for multiple catheter securement and stability products. According to the Company, the new agreement will allow Premier's health care provider members to take advantage of special pricing and terms pre-negotiated by Premier. 3M informed that the agreement covers products including Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressings, Tegaderm™ I.V. Advanced Securement Dressings, and the 3M™ PICC/ CVC Securement Device + Tegaderm™ I.V. Advanced Securement Dressing, a sutureless securement system. "The products covered by this purchasing agreement offer a unique mix of versatility and reliability, applying 3M's expertise in transparent films and adhesives to improve patient care and safety, clinician confidence and overall cost of care," said Brent Ashton, Global Business Director for 3M Critical & Chronic Care Solutions. The full research reports on 3M are available to download free of charge at:

http://www.analystsreview.com/Aug-29-2014/MMM/report.pdf

--
GoPro, Inc. Research Reports
On August 25, 2014, GoPro, Inc. (GoPro) announced the launch of its new Fetch mount, the Company's first pet accessory, which allows dog owners to document life from a dog's point of view. The Company informed that Fetch dog harness has two mount locations for HERO cameras - one on the back for over-the-head shots and another on the chest for a field of view closer to all the action. "We designed Fetch to meet the unique needs and usage for pets and can't wait to see the images and videos that owners will capture and share now that they have a mount specifically for their dog," said Paul Osborne, GoPro's Senior Director of product management. GoPro said that its Fetch mount is fully adjustable and can fit small dogs of 15 pounds (7 kilograms) to large breeds up to 120 pounds (54 kilograms). The full research reports on GoPro are available to download free of charge at:

http://www.analystsreview.com/Aug-29-2014/GPRO/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review